Market Cap 3.47B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 6,587,800
Avg Vol 8,164,194
Day's Range N/A - N/A
Shares Out 306.61M
Stochastic %K 51%
Beta 1.20
Analysts Strong Sell
Price Target $16.12

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
tranq19
tranq19 Aug. 25 at 10:09 AM
$ABCL insiders thought process “we really made the phase 2 trial data public and they’re letting us buy more at $11????”
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 9:56 AM
$ABCL Yesterday action was a classic bear trap by the market manipulators 👀 It was clearly a setup… many investors will be chasing today!!! Shorts time to cover is NOW!!
0 · Reply
USAEquityResearch
USAEquityResearch Aug. 25 at 9:36 AM
$ABCL 📊 USAEquityResearch ▼ 10.61 (-6.27%) Trend: Bullish 📈 RSI (14): 77.6 — overbought, extended, caution warranted MACD: bullish, above signal line and rising Volume: below average 📌 Key Levels Resistance: 12.01 | Support: 5.29 20-MA: 8.65 | 50-MA: 7.32 💼 Fundamentals Mkt Cap: $3.44B FCF: $-46.43M (-0.14/sh) Total Debt: $135.62M D/E: 15.13 📉 Options (exp 2026-09-18) ATM IV: 3.1% | Skew: +0.0% (balanced) Max Pain: 1.00 Educational content only. Not financial advice. Full data, options chain & financials: https://usaequityresearch.com/stocks/ABCL
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 9:11 AM
$ABCL SHORTS RUNNING TOWARDS THE EXITS TODAY!!! $ABCL insider buying continues. Director Michael Hayden bought another 53,613 shares at $10.64 (~$570K) on Aug. 24. With his Aug. 12 buy, that’s exactly 100,000 shares for ~$1.05M. The CFO and another director also bought recently. Insiders aren’t waiting. Another buy from an insider yesterday ✅ Insane confidence by the team🔥
1 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 6:28 AM
$ABCL $ABCL Never seen insiders of a company net buy at a rate like this 👀💯 truly incredible!!!! they are a smart company they know momentum matters 🔥 drawing straws on who buys first Another buy from an insider yesterday ✅ Insane confidence by the team🔥
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 5:51 AM
$ABCL $ABCL we are too cheap, and they know it…
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 5:50 AM
$ABCL Interesting - CFO buying is always the one I watch closest, they know the numbers. Hayden twice plus multiple directors piling in... that's real conviction. Wonder what they're seeing that we don't know yet.
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 5:44 AM
$ABCL $ABCL $571,000 👀👏👏👏👀👀👀 (not pocket change!) Yes please!! ANOTHER INSIDE PURCHASE. 53,613 shares purchased today at $10.64 today. The writing is on the wall folks. Insiders think that we are going UP. Long and strong!
0 · Reply
desiguy
desiguy Aug. 25 at 12:09 AM
$ABCL watch next big buy lot from Thermopylae in the next few days
0 · Reply
DeMampCamp
DeMampCamp Aug. 24 at 10:39 PM
$ABCL Continued insider purchases, if insiders are buying then you should be too! Cheers all!
0 · Reply
Latest News on ABCL
AbCellera announces $200M common stock, warrants offering

2026-08-11T20:05:47.000Z - 13 days ago

AbCellera announces $200M common stock, warrants offering


AbCellera price target raised to $30 from $12 at Truist

2026-08-11T13:35:37.000Z - 13 days ago

AbCellera price target raised to $30 from $12 at Truist


AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 8:00 AM EDT - 15 days ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 15 days ago

AbCellera Biologics Transcript: Study result


AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 15 days ago

AbCellera Biologics Press release: Study result


AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:30 AM EDT - 15 days ago

AbCellera Biologics Slides: Study result


AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:20:50.000Z - 19 days ago

AbCellera price target raised to $9 from $8 at Stifel


AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 19 days ago

AbCellera Biologics Earnings Call Transcript: Q2 2026


AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 19 days ago

AbCellera Biologics Slides: Q2 2026


AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 19 days ago

AbCellera Biologics Earnings release: Q2 2026


AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 19 days ago

AbCellera Biologics Quarterly report: Q2 2026


AbCellera Reports Q2 2026 Business Results

Aug 5, 2026, 4:05 PM EDT - 19 days ago

AbCellera Reports Q2 2026 Business Results


AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 7 weeks ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 7 weeks ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 7 weeks ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera Biologics Slides: Corporate presentation

May 1, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 6 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 7 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference

Nov 13, 2025, 8:00 AM EST - 10 months ago

AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 10 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


tranq19
tranq19 Aug. 25 at 10:09 AM
$ABCL insiders thought process “we really made the phase 2 trial data public and they’re letting us buy more at $11????”
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 9:56 AM
$ABCL Yesterday action was a classic bear trap by the market manipulators 👀 It was clearly a setup… many investors will be chasing today!!! Shorts time to cover is NOW!!
0 · Reply
USAEquityResearch
USAEquityResearch Aug. 25 at 9:36 AM
$ABCL 📊 USAEquityResearch ▼ 10.61 (-6.27%) Trend: Bullish 📈 RSI (14): 77.6 — overbought, extended, caution warranted MACD: bullish, above signal line and rising Volume: below average 📌 Key Levels Resistance: 12.01 | Support: 5.29 20-MA: 8.65 | 50-MA: 7.32 💼 Fundamentals Mkt Cap: $3.44B FCF: $-46.43M (-0.14/sh) Total Debt: $135.62M D/E: 15.13 📉 Options (exp 2026-09-18) ATM IV: 3.1% | Skew: +0.0% (balanced) Max Pain: 1.00 Educational content only. Not financial advice. Full data, options chain & financials: https://usaequityresearch.com/stocks/ABCL
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 9:11 AM
$ABCL SHORTS RUNNING TOWARDS THE EXITS TODAY!!! $ABCL insider buying continues. Director Michael Hayden bought another 53,613 shares at $10.64 (~$570K) on Aug. 24. With his Aug. 12 buy, that’s exactly 100,000 shares for ~$1.05M. The CFO and another director also bought recently. Insiders aren’t waiting. Another buy from an insider yesterday ✅ Insane confidence by the team🔥
1 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 6:28 AM
$ABCL $ABCL Never seen insiders of a company net buy at a rate like this 👀💯 truly incredible!!!! they are a smart company they know momentum matters 🔥 drawing straws on who buys first Another buy from an insider yesterday ✅ Insane confidence by the team🔥
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 5:51 AM
$ABCL $ABCL we are too cheap, and they know it…
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 5:50 AM
$ABCL Interesting - CFO buying is always the one I watch closest, they know the numbers. Hayden twice plus multiple directors piling in... that's real conviction. Wonder what they're seeing that we don't know yet.
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 5:44 AM
$ABCL $ABCL $571,000 👀👏👏👏👀👀👀 (not pocket change!) Yes please!! ANOTHER INSIDE PURCHASE. 53,613 shares purchased today at $10.64 today. The writing is on the wall folks. Insiders think that we are going UP. Long and strong!
0 · Reply
desiguy
desiguy Aug. 25 at 12:09 AM
$ABCL watch next big buy lot from Thermopylae in the next few days
0 · Reply
DeMampCamp
DeMampCamp Aug. 24 at 10:39 PM
$ABCL Continued insider purchases, if insiders are buying then you should be too! Cheers all!
0 · Reply
SocioCobb
SocioCobb Aug. 24 at 9:59 PM
$ABCL Checks some big boy boxes!
0 · Reply
psyxopathis
psyxopathis Aug. 24 at 9:37 PM
0 · Reply
DeMampCamp
DeMampCamp Aug. 24 at 9:29 PM
0 · Reply
Themk
Themk Aug. 24 at 8:05 PM
$ABCL unloaded half today we will see if I regret it will rebuy if it comes down.
1 · Reply
Bullock3000
Bullock3000 Aug. 24 at 7:39 PM
$ABCL MMs selling into any bid Day 3. They dont want run too fast and trigger a halt. So, this what they are doing. The Option Flow delta is negative for the first day I have observed. Their is plenty of liquidity down to $6.
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 24 at 6:19 PM
$ABCL $ABCL this video is aging like fine wine. I have watched it many times already, but watching it back after ABCL635 INCREDIBLE data, just hits different. ABCL almost certainly has their winner/blockbuster on the FIRST TRUE SHOT ON GOAL. I cannot emphasize how bullish I am on this company. I hold a ton of shares with 100% portfolio allocation with a set it and forget it mentality, and will continue to add on weakness. I sleep like a baby at night! Peter Thiel's book Zero to One: "You should focus relentlessly on something you're good at doing, but before that you must think hard about whether it will be valuable in the future." Carl Hansen has thought long and hard about the future. He has all of his wealth in ABCL. Insiders keep buying without any selling. He's an intellectual, a patriot, and most importantly a deep THINKER! Never bet against a person like him. Slow at first, then all at once...
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 24 at 6:15 PM
$ABCL $ABCL - The Thesis: Insider buying doesn't guarantee market-beating returns, but economic theory backs it as a strong signal for future performance. Nuance matters though — in banking, for example, CFO purchases historically outperform CEO purchases, which in turn outperform the market. For me, insiders carry immense informational value — especially in complex, technical sectors like biotech. With $ABCL , I understood the thesis on paper. But understanding a thesis and pulling the trigger are two different things. That's where the insiders stepped in. I don't think I've seen conviction this widespread across every level of an organization before. We started accumulating around $3/share and kept adding over time.
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 24 at 6:13 PM
$ABCL $ABCL may be to biotech what $PLTR became to enterprise software. Not a bet on one product, but a vertically integrated system that discovers, develops and manufactures antibodies while learning from every program. The market may be pricing a molecule. The real bet is the machine
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 24 at 6:12 PM
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 24 at 6:11 PM
$ABCL Best In Class After Phase 2 on a Blockbuster in the First Shot is validation of Platform into
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 24 at 5:42 PM
$ABCL CHART 📈 setting up Nicely! Very BIG BUYS in $300,000-$400,000’s. Has been CONSOLIDATING around $10.60’s-$10.80’s. Getting READY for the next LEG UP. 11’sss Coming up and then the real fun STARTS this week $13-$15’ssss. GET READY!! BUY ALL YOU CAN NOW!! YOU WILL THANK ME LATER.
0 · Reply
Biker68
Biker68 Aug. 24 at 5:40 PM
$ABCL Today will probably leave a (common) gap on no news and no particular volume. It will probably be filled soon!
0 · Reply